Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Recommendation of "Hold" by Brokerages
Pediatrix Medical Group, Inc. (NYSE:MD) Given Average Recommendation of "Hold" by Brokerages
Pediatrix Medical Group, Inc. (NYSE:MD – Get Rating) has been given a consensus recommendation of "Hold" by the eight analysts that are presently covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year target price among analysts that have issued a report on the stock in the last year is $24.67.
據MarketBeat Ratings報道，Pediatrix Medical Group，Inc.(紐約證券交易所代碼：MD-GET評級)已被目前負責該股票的八位分析師一致建議持有。四位研究分析師對該股的評級為持有建議，一位分析師給出了買入建議。在過去一年發佈該股報告的分析師中，平均一年目標價為24.67美元。
Several research firms have recently commented on MD. BMO Capital Markets reduced their price target on Pediatrix Medical Group from $25.00 to $23.00 and set a "market perform" rating for the company in a research report on Wednesday, August 10th. Credit Suisse Group decreased their price target on shares of Pediatrix Medical Group from $30.00 to $28.00 and set an "outperform" rating for the company in a research report on Thursday, August 11th. Finally, Deutsche Bank Aktiengesellschaft cut their price objective on shares of Pediatrix Medical Group from $24.00 to $16.00 in a research report on Tuesday, May 10th.
幾家研究公司最近對MD發表了評論。BMO Capital Markets在8月10日(星期三)的一份研究報告中將Pediatrix Medical Group的目標價從25.00美元下調至23.00美元，併為該公司設定了“市場表現”評級。瑞士信貸集團在8月11日(星期四)的一份研究報告中將Pediatrix Medical Group的股票目標價從30.00美元下調至28.00美元，併為該公司設定了“跑贏大盤”的評級。最後，德意志銀行Aktiengesellschaft在5月10日星期二的一份研究報告中將Pediatrix Medical Group的股票目標價從24.00美元下調至16.00美元。
Hedge Funds Weigh In On Pediatrix Medical Group
對衝基金入股Pediatrix Medical Group
Several hedge funds have recently modified their holdings of MD. Envestnet Asset Management Inc. increased its holdings in shares of Pediatrix Medical Group by 4.2% in the fourth quarter. Envestnet Asset Management Inc. now owns 68,203 shares of the company's stock valued at $1,856,000 after purchasing an additional 2,739 shares during the period. Victory Capital Management Inc. raised its position in Pediatrix Medical Group by 77.2% during the 1st quarter. Victory Capital Management Inc. now owns 58,243 shares of the company's stock worth $1,079,000 after buying an additional 25,378 shares during the last quarter. Granite Investment Partners LLC lifted its stake in Pediatrix Medical Group by 3.5% during the 4th quarter. Granite Investment Partners LLC now owns 612,371 shares of the company's stock valued at $16,663,000 after acquiring an additional 20,599 shares during the period. Palisade Capital Management LLC NJ boosted its holdings in shares of Pediatrix Medical Group by 0.9% in the 4th quarter. Palisade Capital Management LLC NJ now owns 648,925 shares of the company's stock valued at $17,657,000 after acquiring an additional 5,770 shares during the last quarter. Finally, SG Americas Securities LLC increased its stake in shares of Pediatrix Medical Group by 403.5% in the fourth quarter. SG Americas Securities LLC now owns 36,806 shares of the company's stock worth $1,001,000 after acquiring an additional 29,496 shares during the period. Institutional investors and hedge funds own 95.98% of the company's stock.
幾家對衝基金最近調整了對MD的持股。Envestnet Asset Management Inc.在第四季度增持了4.2%的Pediatrix Medical Group股票。Envestnet Asset Management Inc.在此期間又購買了2,739股，目前持有68,203股該公司股票，價值1,856,000美元。第一季度，勝利資本管理公司將其在Pediatrix Medical Group的持倉提高了77.2%。勝利資本管理公司現在持有58,243股該公司股票，價值1,079,000美元，該公司在上個季度又購買了25,378股。Granite Investment Partners LLC在第四季度增持了Pediatrix Medical Group 3.5%的股份。在此期間增持了20,599股後，Granite Investment Partners LLC現在擁有612,371股該公司的股票，價值16,663,000美元。新澤西州Palisade Capital Management LLC在第四季度增持了Pediatrix Medical Group的股票0.9%。新澤西州Palisade Capital Management LLC現在擁有該公司648,925股股票，價值17,657,000美元，上個季度又收購了5,770股。最後，SG America Securities LLC在第四季度增持了403.5%的Pediatrix Medical Group股票。在此期間，SG America Securities LLC額外收購了29,496股，目前擁有36,806股該公司股票，價值1,001,000美元。機構投資者和對衝基金持有該公司95.98%的股票。
Pediatrix Medical Group Stock Performance
兒科醫療集團股票表現
Pediatrix Medical Group (NYSE:MD – Get Rating) last announced its quarterly earnings results on Thursday, August 4th. The company reported $0.47 earnings per share for the quarter, topping the consensus estimate of $0.43 by $0.04. The firm had revenue of $486.00 million during the quarter, compared to analysts' expectations of $491.54 million. Pediatrix Medical Group had a net margin of 4.30% and a return on equity of 16.15%. The company's revenue was up 2.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.36 EPS. As a group, equities research analysts forecast that Pediatrix Medical Group will post 1.71 EPS for the current fiscal year.
Pediatrix醫療集團(紐約證券交易所代碼：MD-GET評級)最近一次公佈季度收益結果是在8月4日星期四。該公司公佈本季度每股收益為0.47美元，比普遍預期的0.43美元高出0.04美元。該公司本季度營收為4.86億美元，高於分析師預期的4.9154億美元。兒科醫療集團的淨利潤率為4.30%，股本回報率為16.15%。與去年同期相比，該公司的收入增長了2.7%。去年同期，該公司每股收益為0.36美元。作為一個整體，股票研究分析師預測，Pediatrix Medical Group本財年的每股收益將達到1.71股。
About Pediatrix Medical Group
關於兒科醫療集團
(Get Rating)
(獲取評級)
Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States and Puerto Rico. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.
兒科醫療集團及其子公司在美國和波多黎各提供新生兒、母嬰、兒科心臟病和其他兒科專科護理服務。它通過新生兒內科專科醫生、新生兒護士執業醫生和其他兒科臨牀醫生，為醫院特定單元內早產或有併發症的嬰兒提供新生兒護理服務。
See Also
另請參閲
- Get a free copy of the StockNews.com research report on Pediatrix Medical Group (MD)
- Could Snap Stock Rebound As Management Restructures?
- MarketBeat: Week in Review 8/29 – 9/2
- Hormel Looks Cheap At These Levels
- Lululemon Set To Soar Into September
- Could Nike Stock be Oversold, but Still Overvalued?
- 免費獲取StockNews.com關於兒科醫療集團(MD)的研究報告
- 隨着管理層重組，股市能否迅速反彈？
- MarketBeat：回顧中的一週8/29-9/2
- 霍梅爾在這些水平上看起來很便宜
- 露露檸檬將飆升至9月
- 耐克股票會被超賣，但仍被高估嗎？
Receive News & Ratings for Pediatrix Medical Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediatrix Medical Group and related companies with MarketBeat.com's FREE daily email newsletter.
接受《兒科醫療集團日報》的新聞和評級-在下面輸入您的電子郵件地址，通過MarketBeat.com的免費每日電子郵件時事通訊接收對Pediatrix Medical Group和相關公司的最新新聞和分析師評級的每日簡要摘要。